Catalyst Wire Dossier Catalyst Wire Dossier

recombinant interferon beta

interferon beta
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for recombinant interferon beta, covering 2022-03-22 to 2022-03-22. Get the full timeline:

Most recent: Clinical Trial Update: Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma [Phase 1, Phase 2]

See pricing